|
Date |
Name |
Title |
Volume |
Trade Price |
Holding Change |
|
5/22/2013
|
ZIEGLER JOHN B
|
Director
|
-31,362
|
$62.00
|
-63.76%
|
|
5/22/2013
|
ZIEGLER JOHN B
|
Director
|
620
|
$44.19
|
1.28%
|
|
5/22/2013
|
ZIEGLER JOHN B
|
Director
|
10,000
|
$49.04
|
26.43%
|
|
5/22/2013
|
ZIEGLER JOHN B
|
Director
|
20,000
|
$42.63
|
112.18%
|
|
5/22/2013
|
ZIEGLER JOHN B
|
Director
|
742
|
$42.42
|
1.55%
|
|
5/16/2013
|
Doherty Catherine T.
|
SVP, Clinical Franchises
|
-276
|
$59.91
|
-0.38%
|
|
5/14/2013
|
BALDWIN JOHN C MD
|
Director
|
-1,214
|
$59.41
|
-12.33%
|
|
5/2/2013
|
WILENSKY GAIL R
|
Director
|
10,000
|
$55.40
|
71.67%
|
|
5/2/2013
|
WILENSKY GAIL R
|
Director
|
-10,000
|
$57.20
|
-41.75%
|
|
5/1/2013
|
RUSCKOWSKI STEPHEN H
|
President and CEO
|
-2,721
|
$56.69
|
-2.89%
|
|
4/15/2013
|
RUSCKOWSKI STEPHEN H
|
President and CEO
|
-4,725
|
$58.96
|
-4.78%
|
|
4/11/2013
|
ZIEGLER JOHN B
|
Director
|
592
|
$41.32
|
3.54%
|
|
4/11/2013
|
ZIEGLER JOHN B
|
Director
|
-1,470
|
$58.35
|
-8.49%
|
|
4/11/2013
|
ZIEGLER JOHN B
|
Director
|
878
|
$36.60
|
5.54%
|
|
3/31/2013
|
ORDONEZ KATHY
|
SVP, Diagnostic Solutions
|
-245
|
$56.23
|
-2.50%
|
|
3/6/2013
|
PREVOZNIK MICHAEL E
|
SVP & General Counsel
|
-778
|
$56.64
|
-1.69%
|
|
3/6/2013
|
PREVOZNIK MICHAEL E
|
SVP & General Counsel
|
-20
|
$56.83
|
-0.04%
|
|
3/6/2013
|
PREVOZNIK MICHAEL E
|
SVP & General Counsel
|
-1,972
|
$56.46
|
-4.19%
|
|
3/5/2013
|
Doherty Catherine T.
|
SVP, Clinical Franchises
|
-934
|
$56.35
|
-1.28%
|
|
3/5/2013
|
RUSCKOWSKI STEPHEN H
|
President and CEO
|
-1,588
|
$56.35
|
-1.59%
|
|
3/5/2013
|
BONGIORNO THOMAS F
|
VP and Corporate Controller
|
-395
|
$56.35
|
-3.00%
|
|
3/5/2013
|
Cohen Jon R
|
SVP and Chief Medical Officer
|
-2,001
|
$56.35
|
-3.56%
|
|
3/5/2013
|
HAGEMANN ROBERT
|
SVP & Chief Financial Officer
|
-3,084
|
$56.35
|
-2.38%
|
|
3/5/2013
|
PREVOZNIK MICHAEL E
|
SVP & General Counsel
|
-1,183
|
$56.35
|
-2.45%
|
|
3/4/2013
|
ORDONEZ KATHY
|
SVP, Diagnostic Solutions
|
-364
|
$55.97
|
-3.58%
|
|
3/4/2013
|
Doherty Catherine T.
|
SVP, Clinical Franchises
|
-661
|
$55.97
|
-0.93%
|
|
3/4/2013
|
BONGIORNO THOMAS F
|
VP and Corporate Controller
|
-171
|
$55.97
|
-1.39%
|
|
3/4/2013
|
HAGEMANN ROBERT
|
SVP & Chief Financial Officer
|
-1,182
|
$55.97
|
-0.95%
|
|
3/4/2013
|
Cohen Jon R
|
SVP and Chief Medical Officer
|
-617
|
$55.97
|
-1.17%
|
|
3/4/2013
|
PREVOZNIK MICHAEL E
|
SVP & General Counsel
|
-463
|
$55.97
|
-1.00%
|
|
2/20/2013
|
ZIEGLER JOHN B
|
Director
|
-2,000
|
$57.42
|
-11.20%
|
|
2/20/2013
|
BRITELL JENNE K
|
Director
|
10,000
|
$55.40
|
69.19%
|
|
2/20/2013
|
BRITELL JENNE K
|
Director
|
-10,000
|
$57.30
|
-40.90%
|
|
2/19/2013
|
PREVOZNIK MICHAEL E
|
SVP & General Counsel
|
-1,442
|
$57.53
|
-3.39%
|
|
2/15/2013
|
Cohen Jon R
|
SVP and Chief Medical Officer
|
-1,142
|
$56.97
|
-2.45%
|
|
2/15/2013
|
BONGIORNO THOMAS F
|
VP and Corporate Controller
|
-279
|
$56.97
|
-2.64%
|
|
2/15/2013
|
HAGEMANN ROBERT
|
SVP & Chief Financial Officer
|
-1,761
|
$56.97
|
-1.51%
|
|
2/15/2013
|
PREVOZNIK MICHAEL E
|
SVP & General Counsel
|
-857
|
$56.97
|
-1.98%
|
|
2/15/2013
|
Doherty Catherine T.
|
SVP, Clinical Franchises
|
-712
|
$56.97
|
-1.10%
|
|
2/12/2013
|
PREVOZNIK MICHAEL E
|
SVP & General Counsel
|
-3,481
|
$57.48
|
-7.43%
|
|
2/10/2013
|
Doherty Catherine T.
|
SVP, Clinical Franchises
|
-1,453
|
$58.45
|
-2.19%
|
|
2/10/2013
|
BONGIORNO THOMAS F
|
VP and Corporate Controller
|
-662
|
$58.45
|
-5.89%
|
|
2/10/2013
|
HAGEMANN ROBERT
|
SVP & Chief Financial Officer
|
-3,726
|
$58.45
|
-3.09%
|
|
2/10/2013
|
Cohen Jon R
|
SVP and Chief Medical Officer
|
-2,426
|
$58.45
|
-4.95%
|
|
2/10/2013
|
PREVOZNIK MICHAEL E
|
SVP & General Counsel
|
-1,358
|
$58.45
|
-2.82%
|
|
1/17/2013
|
PFEIFFER GARY M
|
Director
|
10,000
|
$55.40
|
71.67%
|
|
1/17/2013
|
PFEIFFER GARY M
|
Director
|
-10,000
|
$60.00
|
-41.75%
|
|
12/31/2012
|
ORDONEZ KATHY
|
SVP, Discovery & Development
|
-239
|
$58.25
|
-2.30%
|
|
10/3/2012
|
HAGEMANN ROBERT
|
SVP & Chief Financial Officer
|
-46,667
|
$64.00
|
-23.19%
|
|
10/3/2012
|
HAGEMANN ROBERT
|
SVP & Chief Financial Officer
|
46,667
|
$40.43
|
30.19%
|
|
9/30/2012
|
ORDONEZ KATHY
|
SVP, Discovery & Development
|
-239
|
$63.19
|
-2.25%
|
|
9/6/2012
|
ZIEGLER JOHN B
|
Director
|
-10,000
|
$62.32
|
-35.90%
|
|
9/6/2012
|
ZIEGLER JOHN B
|
Director
|
10,000
|
$55.40
|
56.01%
|
|
8/15/2012
|
WILENSKY GAIL R
|
Director
|
20,000
|
$30.46
|
143.35%
|
|
8/15/2012
|
WILENSKY GAIL R
|
Director
|
-20,000
|
$59.24
|
-58.91%
|
|
8/10/2012
|
BUEHLER WILLIAM F
|
Director
|
10,000
|
$55.40
|
41.24%
|
|
8/10/2012
|
BUEHLER WILLIAM F
|
Director
|
20,000
|
$30.46
|
82.47%
|
|
8/10/2012
|
BUEHLER WILLIAM F
|
Director
|
-20,000
|
$59.34
|
-45.20%
|
|
8/10/2012
|
BUEHLER WILLIAM F
|
Director
|
-10,000
|
$59.24
|
-29.20%
|
|
8/8/2012
|
BALDWIN JOHN C MD
|
Director
|
-1,770
|
$59.98
|
-15.23%
|
|
8/8/2012
|
BALDWIN JOHN C MD
|
Director
|
10,000
|
$55.40
|
86.07%
|
|
8/8/2012
|
Doherty Catherine T.
|
SVP, Physician Services
|
-40,000
|
$60.11
|
-37.73%
|
|
8/8/2012
|
Doherty Catherine T.
|
SVP, Physician Services
|
40,000
|
$52.24
|
60.69%
|
|
8/8/2012
|
BALDWIN JOHN C MD
|
Director
|
-10,000
|
$60.00
|
-46.26%
|
|
8/7/2012
|
RUSCKOWSKI STEPHEN H
|
President and CEO
|
5,000
|
$59.34
|
7.93%
|
|
8/3/2012
|
ZIEGLER JOHN B
|
Director
|
-2,800
|
$59.26
|
-13.56%
|
|
8/1/2012
|
PREVOZNIK MICHAEL E
|
SVP & General Counsel
|
31,778
|
$24.76
|
66.16%
|
|
8/1/2012
|
PREVOZNIK MICHAEL E
|
SVP & General Counsel
|
54,667
|
$52.24
|
68.50%
|
|
8/1/2012
|
PREVOZNIK MICHAEL E
|
SVP & General Counsel
|
-86,445
|
$58.68
|
-64.24%
|
|
7/31/2012
|
PREVOZNIK MICHAEL E
|
SVP & General Counsel
|
11,408
|
$24.76
|
31.15%
|
|
7/31/2012
|
PREVOZNIK MICHAEL E
|
SVP & General Counsel
|
28,814
|
$24.76
|
78.68%
|
|
7/31/2012
|
PREVOZNIK MICHAEL E
|
SVP & General Counsel
|
-28,814
|
$58.59
|
-44.03%
|
|
7/12/2012
|
STANZIONE DANIEL
|
Director
|
20,000
|
$30.46
|
66.28%
|
|
7/12/2012
|
STANZIONE DANIEL
|
Director
|
-30,000
|
$62.00
|
-59.79%
|
|
7/12/2012
|
STANZIONE DANIEL
|
Director
|
10,000
|
$55.40
|
49.56%
|
|
6/30/2012
|
ORDONEZ KATHY
|
SVP, Discovery & Development
|
-239
|
$59.77
|
-2.20%
|
|
6/29/2012
|
BONGIORNO THOMAS F
|
VP and Corporate Controller
|
-15,000
|
$59.54
|
-57.75%
|
|
6/29/2012
|
ZIEGLER JOHN B
|
Director
|
736
|
$31.72
|
3.56%
|
|
6/29/2012
|
ZIEGLER JOHN B
|
Director
|
724
|
$30.53
|
3.38%
|
|
6/29/2012
|
ZIEGLER JOHN B
|
Director
|
-1,460
|
$60.00
|
-6.60%
|
|
6/29/2012
|
BONGIORNO THOMAS F
|
VP and Corporate Controller
|
15,000
|
$52.24
|
137.10%
|
|
6/28/2012
|
ZIEGLER JOHN B
|
Director
|
20,000
|
$30.46
|
96.83%
|
|
6/28/2012
|
ZIEGLER JOHN B
|
Director
|
-20,000
|
$59.00
|
-49.20%
|
|
5/30/2012
|
ZIEGLER JOHN B
|
Director
|
382
|
$28.42
|
1.85%
|
|
5/30/2012
|
ZIEGLER JOHN B
|
Director
|
482
|
$30.28
|
2.29%
|
|
5/30/2012
|
ZIEGLER JOHN B
|
Director
|
-864
|
$58.13
|
-4.02%
|
|
5/16/2012
|
Doherty Catherine T.
|
SVP, Physician Services
|
-343
|
$57.18
|
-0.52%
|
|
5/13/2012
|
Cohen Jon R
|
SVP, Hosp. Services and CMO
|
-2,991
|
$57.66
|
-5.87%
|
|
5/8/2012
|
RUSCKOWSKI STEPHEN H
|
President and CEO
|
20,000
|
$56.89
|
46.47%
|
|
5/8/2012
|
BONGIORNO THOMAS F
|
VP and Corporate Controller
|
-1
|
$56.83
|
-100.00%
|
|
5/2/2012
|
PFEIFFER GARY M
|
Director
|
10,000
|
$53.27
|
83.49%
|
|
5/2/2012
|
PFEIFFER GARY M
|
Director
|
-10,000
|
$58.30
|
-45.50%
|
|
5/1/2012
|
BONGIORNO THOMAS F
|
VP and Corporate Controller
|
-2,305
|
$58.43
|
-99.96%
|
|
5/1/2012
|
BONGIORNO THOMAS F
|
VP and Corporate Controller
|
-7,610
|
$57.50
|
-41.02%
|
|
5/1/2012
|
BALDWIN JOHN C MD
|
Director
|
8,000
|
$49.94
|
66.79%
|
|
5/1/2012
|
BALDWIN JOHN C MD
|
Director
|
-10,334
|
$57.50
|
-51.73%
|
|
4/30/2012
|
MOHAPATRA SURYA N
|
Chairman, President & CEO
|
-26,893
|
$57.51
|
-9.94%
|
|
4/2/2012
|
ORDONEZ KATHY
|
SVP, Discovery & Development
|
-239
|
$61.04
|
-2.15%
|
|
4/2/2012
|
HAGEMANN ROBERT
|
SVP & Chief Financial Officer
|
-46,666
|
$62.00
|
-23.19%
|
|
4/2/2012
|
HAGEMANN ROBERT
|
SVP & Chief Financial Officer
|
46,666
|
$40.43
|
30.19%
|